Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC
Print Options
PrintThe Whole
Directive
PrintThis
Annex
only
Changes over time for: ANNEX IV
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Status:
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
ANNEX IVU.K.BASIC TESTING REQUIREMENTS FOR WHOLE BLOOD AND PLASMA DONATIONS
The following tests must be performed for whole blood and apheresis donations, including autologous predeposit donations:
ABO Group (not required for plasma intended only for fractionation)
Rh D Group (not required for plasma intended only for fractionation)
testing for the following infections in the donors:
Hepatitis B (HBs-Ag)
Hepatitis C (Anti-HCV)
HIV 1/2 (Anti-HIV 1/2)
Additional tests may be required for specific components or donors or epidemiological situations.
Back to top